A carregar...

Killing of Borrelia burgdorferi by Antibody Elicited by OspA Vaccine Is Inefficient in the Absence of Complement

A Lyme disease vaccine, based on the Borrelia burgdorferi lipoprotein OspA, has recently undergone phase III trials in humans. The results of one of these trials indicate that vaccine efficacy positively correlates with anti-OspA antibody titer. Spirochete killing within the tick vector midgut, upon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nowling, Jena M., Philipp, Mario T.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 1999
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC96334/
https://ncbi.nlm.nih.gov/pubmed/9864253
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!